Welcome to our new e-newsletter,
“
BioBlast!” While a few in the past may have considered Oklahoma a biotechnology hotbed, many are now learning that it is truly a place with countless opportunities for technology partnerships and development. As the home of the Oklahoma Medical Research Foundation, the state of Oklahoma is gaining national recognition for cutting-edge biotechnology R&D and commercialization.
Established in 1946 as a private medical research Foundation, OMRF has gained national and international prominence in its areas of research specialization. For example, OMRF is recognized as a national center of excellence for autoimmune R&D. With a history of developing three lifesaving drugs (Ceprotin, Soliris and Xigris) that serve patient needs, advancing several others through the development pipeline, and creating extremely successful biotechnology companies (like Alexion Pharma, Comentis, Crescendo Bio, etc.), OMRF has established a record of technology commercialization that is second to none. Our Office of Technology Ventures (OTV) facilitates the translation and commercialization of OMRF inventions and assists our scientific staff in building collaborations with industrial partners.
OTV has successfully marketed, licensed and commercialized groundbreaking OMRF technologies to pharmaceutical, diagnostic and research reagent companies around the world and continues to search for homes for new technologies. Our team is growing fast and is focused on increasing the revenue and collaboration base that supports OMRF’s research mission. This seasonal e-newsletter is our latest effort to reach out to our friends and collaborators to provide a periodic update about the latest research events, innovative technology developments and new industry collaborations at OMRF.
Learn more about OMRF and its researchers at omrf.org. Or contact me directly at manu-nair@omrf.org and my team and I will be happy to visit with you.
Meet our team
Our Technology Ventures team would love to share details about the exciting work underway here in Oklahoma City, and we’re ready to answer all your questions.
|
